Anemia Studies in Chronic Kidney Disease (CKD): Erythropoiesis Via a Novel Prolyl Hydroxylase Inhibitor (PHI) Daprodustat in Non-Dialysis Subjects Evaluating Hemoglobin (Hgb) and Quality of Life (ASCEND-NHQ)

NCT03409107 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

614

Enrollment

INDUSTRY

Sponsor class

Conditions

Anaemia

Interventions

DRUG: Daprodustat (GSK1278863)
DRUG: Placebo
DRUG: Iron therapy

Sponsor

GlaxoSmithKline